- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- February 2024
- 126 Pages
Global
From €4558EUR$4,750USD£3,925GBP
- Report
- August 2022
- 175 Pages
Global
From €9115EUR$9,500USD£7,851GBP
- Report
- October 2023
- 160 Pages
Global
From €2877EUR$2,999USD£2,478GBP
Tavaborole is a topical antifungal drug used to treat fungal infections of the skin, such as athlete's foot, jock itch, and ringworm. It is a member of the boron-containing antifungal class of drugs, and is available in both prescription and over-the-counter forms. Tavaborole is used to treat a variety of fungal infections, including those caused by Candida, Trichophyton, and Epidermophyton species. It is also used to treat onychomycosis, a fungal infection of the nails.
Tavaborole is an important drug in the treatment of infectious diseases, as it is effective against a wide range of fungal infections. It is generally well-tolerated, with few side effects. It is also relatively inexpensive, making it an attractive option for those who cannot afford more expensive treatments.
The Tavaborole market is highly competitive, with a number of companies offering products containing the drug. These include Bayer, Novartis, Merck, Pfizer, and GlaxoSmithKline. Show Less Read more